Huijie Guo
- Cancer Research top 10%
- NF-κB Signaling Pathways 5
- MicroRNA in disease regulation 2
- Pharmacology top 10%
-
- Gut microbiota and health 3
- Bioactive natural compounds 3
-
- Autophagy in Disease and Therapy 4
- Hepatitis B Virus Studies 3
-
- Immune Response and Inflammation 3
-
- Cytokine Signaling Pathways and Interactions 3
- Co-authors
- Liuqi YangXiujie WangCaiyu LinLi WangChunfen MoYantang WangLihua DongQiang Zou
In The Last Decade
Huijie Guo
34 papers receiving 862 citations
Peers
Comparison fields: 5 of 95
- Cancer Research 223
- Complementary and alternative medicine 62
- Genetics 77
- Pharmacology 62
- Molecular Biology 456
Countries citing papers authored by Huijie Guo
This map shows the geographic impact of Huijie Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huijie Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huijie Guo more than expected).
Fields of papers citing papers by Huijie Guo
This network shows the impact of papers produced by Huijie Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huijie Guo. The network helps show where Huijie Guo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huijie Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 8 | |
| 6 | 2022 | 5 | |
| 7 | 2022 | 1 | |
| 8 | 2021 | 1 | |
| 9 | 2020 | 27 | |
| 10 | 2020 | 44 | |
| 11 | 2020 | 44 | |
| 12 | 2020 | 7 | |
| 13 | 2019 | 3 | |
| 14 | 2019 | 18 | |
| 15 | 2019 | 5 | |
| 16 | 2019 | 8 | |
| 17 | 2018 | 20 | |
| 18 | 2014 | 32 | |
| 19 | 2013 | 94 | |
| 20 | 2012 | 141 |
About Huijie Guo
Huijie Guo is a scholar working on Cancer Research, Geriatrics and Gerontology and Pharmacology, having authored 38 papers that have together received 872 indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (5 papers), Autophagy in Disease and Therapy (4 papers), Hepatitis B Virus Studies (3 papers), Gut microbiota and health (3 papers), Bioactive natural compounds (3 papers), Immune Response and Inflammation (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (223 citations), Complementary and alternative medicine (62 citations) and Genetics (77 citations). Huijie Guo has collaborated with scholars based in China and Israel. Frequent co-authors include Liuqi Yang, Xiujie Wang, Caiyu Lin, Li Wang, Chunfen Mo, Li Wang, Yantang Wang, Lihua Dong, Qiang Zou and Hong Wang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.